I took our SEO to a whole new level, and the results were astonishing. From just $12K in ad spend, we skyrocketed to $1.6M in revenue. Let me share how building authority, optimizing conversion signals, and setting up CRM feedback loops made our PPC scalable.
You might already be familiar with how important SEO is for improving traffic and authority, but what isn’t discussed enough is its impact on other channels like PPC. This case study reveals how we scaled performance marketing in the high-consideration B2B medical device market by nailing our SEO fundamentals.
Marketing a premium pelvic floor chair isn’t your typical ad campaign. This device has a lengthy sales cycle and relies heavily on medical expertise. Our customers range from doctors to physiotherapists, all of whom demand reliable clinical evidence and credibility.
In markets like ours, when common performance tactics fell short, building credibility and authority was key. Without trust in our products and services, performance simply couldn’t scale. I’ve learned that no optimization works without it.
Starting 2023, our Google Ads campaigns were launched with limited SEO. The lack of optimization led to underattribution and resulted in a minimal scaling effect. We also dealt with delays in Google Ads bidding algorithms due to conversion tracking issues.
Despite these challenges, early campaigns confirmed there was a demand. I realized that fixing the surrounding system was necessary to capitalize on this potential in the long run.
By mid-2024, I shifted the focus to treating SEO as a central part of our revenue strategy rather than an additional enhancement. Rather than chasing quick rankings, we prioritized building authority in pelvic health. Our strategy involved educational content, mapping out the entire informational landscape around pelvic health issues.
Our shift paid off. We invested in long-form content, structured it well, and embedded supporting visuals. This approach transformed us into a trusted resource over time and improved our credibility, which is essential in medical markets.
Our biggest success came from leveraging partnerships with clinics and medical professionals. Providing ready-to-use content allowed us to establish valuable backlinking opportunities in exchange for using our resources. These links enhanced our visibility and authority in healthcare sectors.
Ultimately, this strategy resulted in a manifold increase in referring domains and significantly boosted our topical authority. Our backlinks were closely aligned with Google’s assessment of expertise and trust.
By late 2024, our top rankings for crucial keywords like ‘Beckenbodenstuhl’ clearly demonstrated our growing organic visibility. Prospects repeatedly encountered our brand in their research phase, reinforcing trust even before they saw our ads.
Our organic presence also reshaped how users engaged with our ads. Familiarity bred trust, and many users chose our advertisements due to previous organic encounters. This effect was even more pronounced in competitor-specific campaigns, where we achieved high click-through rates.
Improving conversion tracking was the next game-changer. Moving away from standard GA4-imported conversions to GTM-native events allowed us to get faster and cleaner signals, optimizing bidding algorithms effectively.
Integrating our HubSpot CRM closed the loop between marketing and sales. We tracked not only the quantity of leads but also their quality, feeding this data back into our Google Ads to optimize really meaningful outcomes.
With $12,000 in ad spend during 2025, our integrated SEO and PPC strategy led to impressive growth. In just two years, we observed a 140% sales increase from 2023-2024, followed by another 79% in 2025. This equated to a fourfold growth in our sales volume fueled by digital marketing.
The key to scaling PPC lies in trust and quality signals, underscored by sound SEO practices. It’s not about one-off optimizations but a holistic system that includes aligned SEO, precise tracking, and insightful CRM feedback.
Complex markets don’t fail because the strategies are wrong; they fail due to incorrect assumptions about simplicity solving complexity.
You can waste a substantial budget on a capable medtech marketing agency if it solves the wrong problem. A trade show specialist, brand studio, account-based marketing team, enterprise media firm, and organic authority partner can all make persuasive pitches, but they are built for different jobs.
Your first decision is therefore not which agency is best. It is which commercial constraint must change next. Once you name that constraint, the medtech agency landscape becomes much easier to navigate.
Choose the bottleneck before you choose the agency
Write a one-sentence diagnosis before you schedule discovery calls: “Our immediate constraint is [problem], among [audience], at [stage of the buying journey], and progress means [business outcome].” If your team cannot complete that sentence, an agency will fill the gap with the services it already sells.
Route your search according to the job that needs to be done:
You need sustained discovery and qualified inbound demand. Look for thought leadership, technical content, SEO, and generative engine optimization. The agency should be able to connect visibility with a defined conversion path, not merely publish content.
You need paid reach at enterprise scale. Look for media buying, audience data, analytics, creative production, landing-page support, and a clear handoff into your CRM and sales process.
Your product is difficult to explain or your company is preparing to raise capital. Start with positioning, message architecture, visual identity, and materials that can be used consistently in customer and investor conversations.
A conference or trade show is the immediate commercial event. A booth specialist can solve the physical experience, but your scope also needs lead capture, meeting preparation, and post-event follow-up.
Your market consists of a finite group of valuable organizations. Account-based marketing is the natural lane. The agency must show how marketing and sales will coordinate around named accounts and multiple stakeholders.
You need a coordinated device launch or brand program across several channels. An integrated medtech agency may reduce handoff friction, provided it has genuine depth in the channels that matter to you.
Do not treat “full service” as automatically better. Breadth helps when your problem crosses channels. It creates unnecessary cost and management overhead when you only need a specialist intervention.
Seven agencies occupy distinct positions in the 2026 landscape
The profiles below reflect a market snapshot updated January 26, 2026. Use them as routing information for a shortlist, not as a substitute for current due diligence. Company size, staffing, client relationships, and service emphasis can change.
Thought leadership combined with SEO and GEO for lead generation
Founder-led; founded in 2009; reported size of 100-250; named work includes Biovia and Altoida
Ask how search visibility, visibility in generative answers, and content engagement connect to qualified lead definitions. Expect a detailed onboarding process and confirm what your subject-matter experts must contribute.
Enterprise, full-service marketing with a concentration in paid advertising and data analytics
Not founder-led; founded in 1969; reported size of 1,000+; named work includes Visionworks and Walgreens
Clarify the dedicated delivery team, minimum viable scope, data requirements, and total operating cost. Enterprise capacity has little value if your account receives a generic team or more infrastructure than it needs.
Brand development and creative marketing for medical and lifestyle brands, including B2C and B2B work
Founder-led; founded in 1997; reported size of 11-50; named work includes Orthofix and FUJIFILM Sonosite
If pipeline is the goal, ask who owns distribution, conversion, and measurement after the brand work is finished. A strong identity is not automatically a demand-generation system.
Brand strategy and visual identity for medtech companies preparing for funding
Founder-led; founded in 2018; reported size of 1-10; named work includes Theragen and Nuvara
Confirm capacity, access to senior staff, the customer or investor validation process, and who executes the brand after fundraising preparation. No marketing agency can promise that branding will secure funding.
Trade show booth design, manufacturing, and installation
Not founder-led; founded in 1985; reported size of 11-50; named work includes HealthGrid
Define the boundary between booth delivery and campaign delivery. Assign responsibility for pre-event outreach, appointments, lead qualification, data capture, and follow-up to Exponents, another partner, or your internal team.
Omnichannel account-based marketing for high-value organizational buyers
Founder-led; founded in 2007; reported size of 11-50; named work includes MedPost and Care Spot
Ask how accounts are selected, how buying-committee roles are mapped, what sales must do, and how engaged accounts become opportunities. Also clarify cost before assuming ABM is efficient for your market.
Integrated branding, multimedia, and traditional marketing for medical device companies
Founder-led; founded in 2019; reported size of 11-50; named work includes Poba Medical and Kaneka Medical
Identify the named specialist for every channel in your scope. Determine what is delivered in-house, what is subcontracted, and who owns integration, reporting, and corrective decisions.
These firms are not interchangeable entries in a league table. Epsilon’s enterprise scale does not make it the natural choice for a startup that needs investor-ready positioning. Distill Health’s funding-oriented brand work does not make it the default choice for a mature manufacturer seeking paid media at scale. Exponents may be highly relevant to a conference deadline while remaining intentionally narrow outside the trade show itself.
Founder involvement, company age, and headcount are context rather than outcomes. A founder-led specialist may offer direct senior attention, but you still need to know who will perform the weekly work. A large firm may provide broader capabilities and resilience, but you still need a dedicated team with relevant experience.
Client names establish adjacency, not success. Ask what the agency delivered, which audience it addressed, how long the work ran, and what changed. A recognizable logo can represent a small project that bears little resemblance to your scope.
Relevant similarity is multidimensional. Product category alone is not enough. Compare the buyer, sales motion, company stage, geographic scope, channel, and internal review process. A consumer campaign and a hospital-enterprise sale can require very different work even when both sit under the medtech label.
Leadership experience matters only if it reaches delivery. Ask who joins the pitch, who designs the strategy, who manages the account, and who creates the work. Get those roles into the scope. Do not assume the founder or senior strategist in discovery will remain involved.
Tenure is a continuity clue. Within this group, reported median employee tenure ranges from 1.7 years at The ABM Agency to 4.6 years at Epsilon. That does not prove quality, but it gives you a reason to ask about turnover, backup coverage, and knowledge transfer.
Reviews require context. Look for comments about the type of work you are buying, responsiveness when a campaign underperforms, and the quality of project oversight. A high average without detail cannot tell you whether the agency can solve your problem.
Media references indicate visibility, not operational competence. They can support an authority assessment, but they do not replace current work samples, named team members, a delivery plan, or access to reporting.
Ask every shortlisted agency to walk through a documented engagement that resembles your situation. Have it explain the starting constraint, its exact scope, the client responsibilities, the approval path, the deliverables, and the business result. If the answer skips from a client logo directly to an outcome, the missing middle is where delivery risk usually sits.
Medtech work also needs an explicit claims-review workflow. Your internal medical, legal, regulatory, or quality reviewers may own approval, but the agency must know when review occurs, how revisions are tracked, and which version is cleared for each channel. If this process remains vague, timelines and budgets can deteriorate after production begins.
Write a scope that matches the agency lane
A useful brief does more than list services. Use this structure: “Help [audience] move from [current state] to [conversion or commercial outcome] by producing [deliverables], distributing them through [channels], and reporting [business and diagnostic measures].” Add your approval roles, required systems, ownership terms, dependencies, and exclusions.
For SEO, thought leadership, and GEO
Name the technical themes, buyer questions, priority audiences, conversion events, subject-matter experts, and owned properties in scope. Require the agency to distinguish traditional search performance from observed brand inclusion or citation in generative answers. Both can contribute to discovery, but they are not the same measurement.
Qualified organic inquiries, target-account visits, completed demo or consultation requests, coverage of problem-led searches, and observed AI-answer visibility are more useful together than traffic alone. Traffic remains a diagnostic measure. It is not proof that the right buyer understood the product or entered a sales conversation.
For paid media and integrated campaigns
Specify the audience data, media channels, creative formats, landing pages, tracking, CRM handoff, and approval workflow. Decide who owns media accounts, analytics access, campaign data, source files, and website changes. Your organization should retain administrative access to the systems and assets it is paying to build; losing access can make a future agency transition expensive and slow.
Make qualified opportunities and pipeline the commercial measures when your sales cycle supports them. Use accepted leads, qualified conversations, landing-page conversion, and acquisition cost as operating indicators. Click-through rate and impressions can diagnose a campaign, but they should not become substitutes for business progress.
For account-based marketing
Define how target accounts enter the program, which stakeholder roles matter, what sales will do, which messages vary by role, and how engagement is recorded. ABM fails quietly when marketing runs account-targeted ads while sales follows an unrelated list and neither side owns the handoff.
Track meaningful engagement across the buying group, meetings with relevant roles, account progression, opportunities, and pipeline. Raw account impressions are not enough. Your agency should also explain what evidence causes it to intensify, change, or stop work on an account.
For branding, fundraising preparation, and trade shows
A brand scope should name the positioning decision, message architecture, visual system, required customer or investor materials, validation method, and internal approvers. Define how the system will reach the website, sales materials, presentations, and campaigns. Otherwise, you can finish with an attractive identity that the commercial team cannot apply consistently.
A trade show scope should connect the physical booth with pre-event outreach, meeting booking, on-site data capture, lead qualification, CRM entry, and follow-up. If the booth provider does not offer those services, assign them elsewhere before the event. Booth traffic is an incomplete result; qualified conversations and subsequent opportunities are the commercial test.
In every lane, separate agency deliverables from client dependencies. Technical interviews, product access, approved claims, customer references, CRM configuration, and executive sign-off can all sit with your team. Put each dependency beside an owner and approval path so neither side can hide a preventable delay inside a status report.
Key takeaways: use the pitch to expose delivery risk
State the bottleneck first: What precise commercial constraint will this engagement change, and which business outcome will show that it changed?
Interrogate the closest example: Which past engagement most closely matches your buyer, product stage, sales motion, and channel? What did the agency itself deliver?
Name the working team: Who owns strategy, account management, content or creative production, media, analytics, and claims coordination after the pitch?
Expose outside dependencies: Which services are subcontracted, which require another partner, and which depend on your internal experts or systems?
Map the approval process: When do technical and claims reviews happen, who resolves conflicting feedback, and how are approved versions controlled?
Protect ownership: Who owns the ad accounts, analytics properties, audience data, CRM records, domains, website access, source files, and finished assets?
Demand decision-grade reporting: Which measures represent commercial outcomes, which are leading indicators, and which merely diagnose activity?
Set correction rules: What evidence will cause the agency to change the message, channel, audience, budget allocation, or scope?
Send the same written brief to every agency on your shortlist and insist that each response addresses the same outcome, responsibilities, evidence, and ownership terms. That makes proposals comparable and prevents a polished pitch from redefining your problem around an agency’s preferred services.
Choose the partner whose lane matches your immediate constraint, whose relevant work survives detailed questioning, and whose named team can explain how delivery becomes a measurable business result. That is a stronger basis for a decision than rank, reputation, or breadth alone.
You may be staring at several polished agency proposals that all promise strategy, content, search visibility, and growth. The difficult part isn’t finding a capable-looking firm. It is determining which firm understands your revenue path, can work safely inside your approval process, and will let you verify what it actually contributes.
Write the brief around the revenue path, not marketing services
Healthcare and medtech sit near each other on an industry map, but they do not automatically create the same agency brief. A provider organization may need to turn local demand into qualified appointment requests. A medtech company may need to educate clinicians, administrators, procurement stakeholders, distribution partners, or other participants before a commercial conversation can advance.
If you ask for SEO, content, paid media, or AI optimization before defining that path, agencies will sell the services they already deliver. Start with the change your organization needs and work backward to the marketing capability.
If you market a practice or care-delivery organization
Name the service line and location you need to support. Local visibility for a specific service is a different assignment from national brand building.
Define a qualified conversion. It might be an appointment request, a call that meets your intake criteria, or a professional referral inquiry. A raw form submission is not automatically a useful lead.
Describe the path after conversion. Tell the agency who receives the inquiry, how eligibility or fit is assessed, and where the result is recorded.
State operational constraints. If a location, clinician, or intake team cannot absorb additional demand, more traffic can create a worse patient experience without improving the business.
List the people who approve medical statements, patient-facing language, advertising claims, and reputation responses. The agency needs to design around that workflow.
If you market a medical technology
Map the audience chain. Separate the people who use the technology, evaluate it, approve it, purchase it, distribute it, and search for information about it.
Name the decision friction. You may need category education, technical explanation, economic justification, evidence discovery, or help distinguishing the product from an established alternative.
Choose a meaningful commercial action. A demo request, distributor inquiry, sales-accepted conversation, or engagement from a target organization can be more informative than undifferentiated lead volume.
Document the evidence boundary. Give the agency the approved language, supporting material, prohibited claims, required review steps, and owner of each decision.
Identify geographic and organizational complexity. A single-market campaign should not be scoped like a multi-region program that must balance central messaging with local relevance.
Turn those decisions into a short brief before you take another sales call. Include the business outcome, audience, current obstacle, desired conversion, geographic scope, approval owners, evidence constraints, available assets, required systems, and definition of a qualified result. Add explicit non-goals as well. If brand awareness is not the assignment, say so. If the agency will not control paid media, website development, or sales operations, say that too.
This brief makes proposals comparable. It also reveals whether an agency can reason from your problem or merely translate its standard package into healthcare language.
Match the agency model to the bottleneck you actually have
Choose a local-search specialist when patients must discover a particular location or service in geographically relevant results. Ask for evidence of location architecture, business-profile management, local content judgment, review workflows, and conversion tracking through intake.
Choose an authority-and-content specialist when your audience cannot make progress without credible education. Ask to see how topics are selected, how subject-matter experts participate, how claims are checked, and how content connects to an intended commercial action.
Choose a technical website and SEO firm when crawlability, site structure, publishing friction, accessibility, performance, or an impending rebuild is the main constraint. Require a clear division between diagnosis, implementation, design, content migration, validation, and ongoing optimization.
Choose a reputation-led agency when trust signals, inconsistent profiles, or the handling of public feedback is obstructing demand. Ask who is authorized to respond, which issues are escalated, and how the work connects to brand and search visibility without exposing sensitive information.
Choose a multi-location or international specialist when central control and local relevance keep colliding. Ask the agency to show how it governs shared templates, local pages, market-specific review, brand consistency, and reporting across regions.
Choose an integrated firm when channel coordination is the bottleneck. A broad agency can be useful when the same strategy must govern web, search, content, advertising, and social execution. Make it identify the owner of the integrated plan; a bundle of separate channel teams is not automatically integration.
Choose a social-and-search model when audience discovery genuinely crosses those surfaces. Require a clear role for each channel and a method for recognizing when social attention creates branded search, site engagement, or a qualified inquiry.
Do not buy a larger service bundle just because it appears more complete. If the real problem is medical-content production, adding paid media and social posting may increase coordination before it increases performance. Conversely, a narrow SEO firm may be the wrong choice when your website, analytics, intake process, and brand message all need coordinated repair.
Ask each agency to identify the bottleneck in its own words. Then ask what it would defer. A credible prioritization includes work that should not happen yet.
That weighting is a useful starting structure, not a universal procurement rule. Adjust the emphasis before opening proposals. A sensitive content program may deserve more emphasis on compliance and subject-matter workflow. A rebuild may require more scrutiny of technical delivery. A highly specialized device may make relevant audience and category experience more important than the size of the agency’s general healthcare portfolio.
Criterion
Benchmark weight
Evidence to request
Average review score
30%
Recurring themes from clients with comparable scopes, including what happened when delivery was difficult. Treat a rating as a lead for verification, not proof by itself.
Healthcare industry experience
25%
Work involving a similar audience, business model, review burden, and conversion path. General healthcare logos do not establish experience with your particular problem.
Leadership experience
15%
The named person accountable for strategy, their relevant background, and their actual involvement after the sale.
Client portfolio size
10%
Relevant active work, team capacity, possible conflicts, and an explanation of how resources will be assigned to your account.
Compliance expertise
10%
An actual workflow for evidence, medical review, advertising review, privacy-sensitive access, escalation, approval, and revision history.
Median employee tenure
5%
The expected delivery team, continuity of key roles, and the handoff plan if a strategist, writer, or account lead changes.
Media references and case studies
5%
Cases that define the starting problem, agency contribution, measurement method, relevant constraints, and result. Ask which parts can be independently verified.
Rate the evidence behind each answer as verified, plausible but unverified, or absent. Keep that confidence judgment separate from the agency’s claimed capability. A beautiful case study with an undefined baseline should not outscore a less dramatic example with a clear method and comparable scope.
Set disqualifiers before scoring. Reasonable examples include refusal to follow your medical or legal review process, uncertainty about who owns core accounts and content, an unexplained need for sensitive data, a material client conflict, or guarantees of rankings and AI recommendations that the agency cannot control. A disqualifier should represent unacceptable exposure, not merely a preference.
Put finalists through one real working session
References and proposals tell you what an agency wants you to believe. A controlled working session shows you how its team thinks. Give every finalist the same redacted scenario and the same information. Do not share real patient information or sensitive commercial material merely to make the exercise realistic.
Present the business problem without prescribing the channel. Ask the team to identify the audience, conversion, unknowns, constraints, and likely bottleneck before proposing tactics.
Request a prioritized first phase. The team should distinguish prerequisites from experiments and explain what it would postpone. Listen for dependencies on your website, analytics, subject-matter experts, intake operation, or sales process.
Test the content workflow. Provide a fictional or already approved example claim and ask how it would become a page, campaign, or answer-ready content asset. Require the team to identify where evidence, medical review, compliance review, and final approval enter the process.
Trace measurement from discovery to business outcome. Ask the agency to draw the path from a search result, AI answer, advertisement, or social interaction through the website and into the system where your organization accepts or rejects the inquiry.
Examine the AI-search plan separately. Ask which user questions it will monitor, how it will assess brand mentions and citations, which on-site changes it expects to make, how structured data fits the work, and how it will distinguish visibility from a qualified outcome.
Review the operating model. Confirm the day-to-day team, decision rights, meeting purpose, reporting inputs, revision process, account ownership, content ownership, data access, and offboarding handoff.
Make compliance visible in the workflow
Compliance expertise should produce more than a badge in a capabilities deck. Ask the agency to draw the route from topic selection to evidence collection, drafting, subject-matter review, compliance or legal review, publication, monitoring, and later revision. Every handoff needs an owner. The agency should also be able to explain what happens when a reviewer rejects a claim or when approved language changes.
If the work could involve information your organization treats as protected or sensitive, let your privacy, security, compliance, and legal owners determine the access and contractual requirements before access is granted. An agency’s familiarity with HIPAA or healthcare advertising standards does not replace your organization’s review or professional legal advice.
Watch how the agency reacts to limits. Strong teams ask for the evidence they need, mark unresolved claims, and adapt the message. Weak teams treat review as a final proofreading step or assume that careful wording can rescue an unsupported promise.
Treat GEO as auditable work, not a separate pile of AI copy
A defensible healthcare GEO program still needs content that is understandable, medically accurate, and connected to authority. A documented cardiology approach combines accessible medical content and authority building with GEO and conventional Google search. Use that combination as a diligence framework, not as proof that any agency can guarantee inclusion in a particular answer.
Ask the finalist to show the chain of reasoning: which audience question matters, what information an adequate answer requires, what your site currently lacks, which approved evidence supports the response, what content or structured information will change, and how visibility will be observed over time. It should also separate work on your own site from third-party authority or mentions that it cannot directly control.
Do not accept isolated screenshots as a complete measurement system. Require a repeatable query set, a record of the conditions under which observations were made, visibility and citation tracking, site-engagement measures, and a connection to qualified commercial or patient-access outcomes. The agency should acknowledge uncertainty and variation instead of converting every appearance into a success claim.
Make reporting follow the lead beyond the form
Marketing reports often stop at the easiest event to count. Your decision should not. Ask who will connect an inquiry to intake acceptance, a scheduled interaction, a sales disposition, or whichever downstream status your organization uses. If that connection cannot be made yet, the proposal should identify the data gap and assign responsibility for closing it.
The agency should distinguish three things: activity it completed, visibility or engagement that followed, and business outcomes that may have multiple causes. That separation protects you from both exaggerated credit and premature blame. It also makes optimization possible because you can see whether the problem is discovery, conversion, qualification, or follow-up.
Key takeaways for a defensible agency decision
Define the audience, business outcome, qualified conversion, approval path, and non-goals before requesting channels or deliverables.
Choose the agency model that removes your present bottleneck. Local search, content authority, technical web work, reputation, integrated marketing, and GEO are different capabilities.
Use weighted criteria to control the decision, but adjust the emphasis before you see agency proposals.
Score the quality of evidence separately from the claimed capability. Comparable work and a transparent method matter more than a familiar logo.
Test finalists with the same redacted working scenario. Observe how they diagnose, prioritize, handle claims, design measurement, and respond to constraints.
Keep medical, privacy, compliance, and legal decisions with the qualified owners inside your organization. Agency expertise should support that governance, not replace it.
Require AI-search work to identify target questions, content and authority gaps, observable changes, measurement limits, and the connection to a meaningful outcome.
Before your next agency call, reduce your assignment to one sentence: for this audience, we need this measurable action to improve, within these evidence and operating constraints. Send the same brief to every finalist and require each one to show its reasoning against it. The best choice is the team that gives you the clearest, safest, and most verifiable path from audience need to business result.
